Sugi Predict

Sugi Predict / Compounds / Ethyl Acetate

Ethyl Acetate

Ethyl Acetate

SCHEMBL48804

CCCC(C)C.CCOC(C)=O

nearest known ligand 0.64

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.64
▸ LMNA P02545 1/20 0.64
▸ HSD17B10 Q99714 1/20 0.64
▸ TSHR P16473 3/20 0.41
▸ PTPN1 P18031 1/20 0.39
▸ ALOX15 P16050 2/20 0.37
▸ MGAM O43451 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ SI P14410 1/20 0.37
▸ MGAM2 Q2M2H8 1/20 0.37
▸ SOAT1 P35610 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ CHRM1 P11229 1/20 0.36
▸ AKR1A1 P14550 1/20 0.36
▸ CHRM3 P20309 1/20 0.36
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ ADRA1A P35348 1/20 0.36
▸ HRH1 P35367 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethyl Acetate SCHEMBL830570 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL6842378 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL8031050 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL3310000 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL6439765 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL3307229 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL15020058 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL6439648 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL832069 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1
Ethyl Acetate SCHEMBL7919087 1.00 ALDH1A1 (0.64) ALDH1A1LMNAHSD17B10TSHRPTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1521 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12037345-B2 Heterobicyclic compounds for inhibiting the activity of SHP2 TAIHO PHARMACEUTICAL CO., LTD. (JP) 2024-07-16 — — US disclosed
WO-2024099517-A1 FLUORESCENT SALTS OF4-HYDROXYBICYCLO[3.3.1]NON-3-ENE-2,9-DIONE DERIVATIVES, AND USE THEREOF Technische Universität Dresden, Körperschaft des öffentlichen Rechts (DE) 2024-05-16 — — WO disclosed
WO-2024099520-A1 4-HYDROXYBICYCLO[3.3.1]NON-3-ENE-2,9-DIONE DERIVATIVES AND USE THEREOF Technische Universität Dresden, Körperschaft des öffentlichen Rechts (DE) 2024-05-16 — — WO disclosed
CN-117580824-A Modulators of integrated stress pathways 卡里科生命科学有限责任公司 2024-02-20 — — CN disclosed
US-20230382931-A1 DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER MEDIVIR AB (SE) 2023-11-30 — — US disclosed
EP-3688000-B1 HYDROCARBON-SOLUBLE HALOGEN AND THIOLATE/MAGNESIUM EXCHANGE REAGENTS ALBEMARLE GERMANY GMBH (DE) 2023-11-08 — — EP disclosed
CN-111491628-B Phenoxy acids for the treatment of neuromuscular disorders NMD制药股份公司 2023-10-13 — — CN disclosed
EP-4237413-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY Calico Life Sciences LLC (US) 2023-09-06 — — EP disclosed
US-20230270750-A1 CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-08-31 — — US disclosed
CN-116472267-A Butyrylcholinesterase reactivating agent 法兰西国由中央军队卫生服务局代表 2023-07-21 — — CN disclosed
CN-86108961-A 1-CARBACEPHALOSPORIN ANTIBIOTICS — 1987-08-05 — — CN disclosed
CN-87100055-A Orally active phosphonyl hydroxyacyl proline and preparation method thereof — 1987-08-05 — — CN disclosed
CN-85109721-A Preparation has the ectoparasite of the no disease homoiothermic animal of control and the method for endoparasite compositions — 1987-07-15 — — CN disclosed
CN-85107235-A As the replacement cinnamyl-2 of anti-inflammatory agent, the manufacture method of 3-Dihydrobenzofuranes and analogue — 1987-04-01 — — CN disclosed
CN-86102482-A Process for preparing leukotriene antagonists — 1987-02-04 — — CN disclosed
CN-85101752-A The preparation method of 2-amido-5-hydroxy-4-methyl pyrimidine derivatives — 1987-01-31 — — CN disclosed
CN-86103227-A The method for preparing the 2-Pyrrolidone derivative — 1987-01-21 — — CN disclosed
CN-85106742-A The preparation method of pyridazinylimidazolicompounds compounds — 1986-12-31 — — CN disclosed
CN-86102923-A The method for preparing antibiotic derivatives — 1986-11-12 — — CN disclosed
CN-85108623-A Preparation has the novel method of the heterocycleamide of medical active — 1986-07-30 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230270750-A1 CARBALDEHYDE OXIMES AS BUTYRYLCHOLINESTERASE REACTIVATORS BCHE, ACHE, CHAT ALDH1A1 239/4885LMNA 2031/4885HSD17B10 591/4885
US-20230382931-A1 DIOXOLANE ANALOGUES OF URIDINE FOR THE TREATMENT OF CANCER ADORA3, DUT, NTPCR ALDH1A1 382/4885LMNA 3139/4885HSD17B10 1959/4885
US-12037345-B2 Heterobicyclic compounds for inhibiting the activity of SHP2 PTPN1, PTPN9, PTPN7 ALDH1A1 3810/4885LMNA 4776/4885HSD17B10 2830/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.